Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Expert Review of Anti-Infective Therapy
|
April 30, 2015
Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis
Sabina Antoniu
Expert Opinion on Investigational Drugs
|
June 19, 2014
Bedoradrine for treating asthma and chronic obstructive pulmonary disease
Sabina Antoniu
Expert Opinion on Biological Therapy
|
April 30, 2014
Epratuzumab for systemic lupus erythematosus
Sabina Antoniu
Expert Opinion on Pharmacotherapy
|
May 2, 2009
Itraconazole for severe asthma with fungal sensitivity
Sabina Antoniu
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 22, 2013
Outpatient palliative care effectiveness: both patients and caregivers can gain
Sabina Antoniu
Annals of Translational Medicine
|
June 14, 2016
Nivolumab for advanced non-small cell lung cancer: an immunologically-mediated tumor checkout
Sabina Antoniu, Ruxandra Ulmeanu
Expert Opinion on Investigational Drugs
|
March 23, 2013
Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study
Sabina Antoniu, Doina Azoicai
Expert Opinion on Drug Safety
|
February 16, 2026
Short-acting beta 2 agonists overuse in asthma: where are we now?
Sabina Antoniu, Theodor Penisoara
Expert Opinion on Investigational Drugs
|
October 12, 2024
Protein phosphatase 2A activators under investigation for smoking-related chronic obstructive pulmonary disease and related disorders
Sabina Antoniu, Setfan Rascu
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 19, 2014
Outcome measures for palliative oxygen therapy: relevance and practical utility
Sabina Antoniu, Florin Mihaltan
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Expert Review of Anti-Infective Therapy
|
April 30, 2015
Novel inhaled combined antibiotic formulations in the treatment of Pseudomonas aeruginosa airways infections in cystic fibrosis
Sabina Antoniu
Expert Opinion on Investigational Drugs
|
June 19, 2014
Bedoradrine for treating asthma and chronic obstructive pulmonary disease
Sabina Antoniu
Expert Opinion on Biological Therapy
|
April 30, 2014
Epratuzumab for systemic lupus erythematosus
Sabina Antoniu
Expert Opinion on Pharmacotherapy
|
May 2, 2009
Itraconazole for severe asthma with fungal sensitivity
Sabina Antoniu
Expert Review of Pharmacoeconomics & Outcomes Research
|
October 22, 2013
Outpatient palliative care effectiveness: both patients and caregivers can gain
Sabina Antoniu
Annals of Translational Medicine
|
June 14, 2016
Nivolumab for advanced non-small cell lung cancer: an immunologically-mediated tumor checkout
Sabina Antoniu, Ruxandra Ulmeanu
Expert Opinion on Investigational Drugs
|
March 23, 2013
Ciprofloxacin DPI in non-cystic fibrosis bronchiectasis: a Phase II randomized study
Sabina Antoniu, Doina Azoicai
Expert Opinion on Drug Safety
|
February 16, 2026
Short-acting beta 2 agonists overuse in asthma: where are we now?
Sabina Antoniu, Theodor Penisoara
Expert Opinion on Investigational Drugs
|
October 12, 2024
Protein phosphatase 2A activators under investigation for smoking-related chronic obstructive pulmonary disease and related disorders
Sabina Antoniu, Setfan Rascu
Expert Review of Pharmacoeconomics & Outcomes Research
|
April 19, 2014
Outcome measures for palliative oxygen therapy: relevance and practical utility
Sabina Antoniu, Florin Mihaltan
Page
of 4